Lucis Pharma Ltd
Registered name: LUCIS PHARMA LTD
Part of Primrose Topco Limited groupLucis Pharma Ltd made £3.5m revenue and £2m profit in the year to 31 Dec 2025.
Lucis Pharma Ltd’s revenue fell 16% to £3.5m in the year to 31 Dec 2025, with £2m profit. The company is classified under “wholesale of pharmaceutical goods” and is based in Leeds; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Leeds, Yorkshire and The Humber
- Age
- 13 yrs · since 2012
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £10.1m | £4.2m | £3.5m |
| Cost of sales | −£6.2m | −£1.3m | −£1.1m |
| Gross profit | £3.9m | £2.9m | £2.5m |
| Operating profit | £2.5m | £2.4m | £2m |
| Profit before tax | £2.5m | £2.4m | £2m |
| Profit after tax | £2.2m | £2.4m | £2m |
| Profit (best available) | £2.2m | £2.4m | £2m |
| Employees (average) | 1 | 3 | — |
| Ratios | |||
| Profit margin | 21.9% | 56.4% | 57.4% |
| Gross margin | 38.9% | 69.4% | 69.3% |
| Revenue per employee | £10.1m | £1.4m | — |
| Profit per employee | £2.2m | £795k | — |
| Growth (year on year) | |||
| Revenue growth | — | ▼58.1% | ▼16.3% |
| Profit growth | — | ▲7.9% | ▼14.8% |
| Headcount growth | — | ▲200% | — |
| Balance sheet — indirect signals, not revenue | |||
| Net assets | — | — | — |
| Source | Accounts · bulk data Apr 2025 | Accounts · bulk data Apr 2025 | Accounts · bulk data Mar 2026 |
How the business works
- Profit margin
- 57.4%
- Profit ÷ revenue.
- Gross margin
- 69.3%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- —
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- —
- Now —
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Primrose Topco Limitedultimate parent75–100%
- Primrose Midco 1 Limited75–100%
- Rosemont Pharmaceuticals Limited75–100%
- Lucis Holdings Limited75–100%
- Lucis Pharma Ltdthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Itf Pharma LtdLondon · Wholesale of pharmaceutical goods
- Revenue
- £3.6m
- Profit
- £320k
- Staff
- 9
- Arena Pharmaceuticals LimitedBuckingham · Wholesale of pharmaceutical goods
- Revenue
- £4.5m
- Profit
- £394k
- Staff
- 3
- Ananta Medicare LtdFulham London · Wholesale of pharmaceutical goods
- Revenue
- £4.7m
- Profit
- £90.9k
- Staff
- 3
- Apellis UK LimitedLondon · Wholesale of pharmaceutical goods
- Revenue
- £4.7m
- Profit
- £127k
- Staff
- 11
- Abacus Medicine Pharma Services LtdFarnborough · Wholesale of pharmaceutical goods
- Revenue
- £6.3m
- Profit
- £348k
- Staff
- 21
- Recordati Rare Diseases UK LimitedMaidenhead · Wholesale of pharmaceutical goods
- Revenue
- £6.4m
- Profit
- £123k
- Staff
- 9
Sources
Latest figures from accounts for the year to 31 Dec 2025 (profit £2m), from the Companies House accounts bulk data published Mar 2026. Spotted an error? Request a correction.
Updated from Companies House on 12 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.